NL-OMON36704已完成3 期
An open label extension study to evaluate long term use of a Food for Special Medical Purposes (FSMP) in patients with mild Alzheimer*s disease who completed the Souvenir II study - Souvenir II Open Label Extension Study
Danone Research - Centre for Specialised Nutrition0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Completion of 24 week study visit Souvenir II study or the Souvenir II MEG sub-study
- •Availability of responsible caregiver
- •Written informed consent of subject and caregiver
排除标准
- •Use of other investigational products
- •Alcohol or drug abuse in opinion of the investigator
- •Uncertainty about willingness, ability, or medical status of subject to comply with protocol requirements
研究者
相似试验
招募中
3 期
An Open-Label Extension Study to Evaluate Long Term Safety and Efficacy of Tildrakizumab in Patients with Psoriatic ArthritisPsoriatic ArthritisJPRN-jRCT2031220622Oshima Satoe35
招募中
1 期
An Open-Label Extension Study to Evaluate Long Term Safety and Efficacy of Tildrakizumab in Patients with Psoriatic Arthritis.Psoriatic ArthritisCTIS2022-501480-41-00Sun Pharmaceutical Industries Limited759
尚未招募
3 期
Study of long term Efficacy and Safety of Tildrakizumab in Subjects With Active Psoriatic Arthritis (PsA)CTRI/2024/07/071189Sun Pharmaceutical Industries Limited
进行中（未招募）
1 期
ong-Term Safety Evaluation of dupilumab in patients with asthmaMedDRA version: 16.1 Level: PT Classification code 10003553 Term: Asthma System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2013-003856-19-ESSanofi-aventis recherche et développement560
招募中
3 期
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of A4250 in Children with Progressive Familial Intrahepatic Cholestasis Types 1 and 2 (PEDFIC 2)NL-OMON54766Albireo AB8